Professor Mark Lowdell, PhD. CSO/CMO: Prof. Lowdell has been a Chief Scientific Officer and Chief Manufacturing Officer since its formation in September 2015.   Prof. Lowdell is Professor of Cell and Tissue Therapy at University College London where he has led a translational immunotherapy group since 1994.  Since February 2009, Prof. Lowdell has also been Director of Cellular Therapy at the Royal Free London NHS Foundation Trust.   He received his PhD in clinical immunology from London Hospital Medical College, University of London in 1992 and is a qualified immunopathologist.  Prof. Lowdell’s education and significant academic and clinical experience with cellular therapies were instrumental in his selection as Chair of the SAB.

Got a question?
858 964 3720
Email Us
dmoss@inmunebio.com
Opening Hours
M - F 8am to 5pm PST